AAAAAA

   
Results: 1-11 |
Results: 11
Carboxyamido-triazole (CAI)- a novel "static" signal transduction inhibitor induces apoptosis in human B-cell chronic lymphocytic leukemia cells
Authors: Waselenko, JK Shinn, CA Willis, CR Flinn, IW Grever, MR Byrd, JC
Citation: Jk. Waselenko et al., Carboxyamido-triazole (CAI)- a novel "static" signal transduction inhibitor induces apoptosis in human B-cell chronic lymphocytic leukemia cells, LEUK LYMPH, 42(5), 2001, pp. 1049-1053
Rituximab using a thrice weekly dosing schedule in B-Cell chronic lymphocytic leukemia and small lymphocytic lymphoma demonstrates clinical activity and acceptable toxicity
Authors: Byrd, JC Murphy, T Howard, RS Lucas, MS Goodrich, A Park, K Pearson, M Waselenko, JK Ling, G Grever, MR Grillo-Lopez, AJ Rosenberg, J Kunkel, L Flinn, IW
Citation: Jc. Byrd et al., Rituximab using a thrice weekly dosing schedule in B-Cell chronic lymphocytic leukemia and small lymphocytic lymphoma demonstrates clinical activity and acceptable toxicity, J CL ONCOL, 19(8), 2001, pp. 2153-2164
Gemcitabine demonstrates in vitro activity against human B-cell chronic lymphocytic leukemia
Authors: Waselenko, JK Grever, MR Shinn, CA Flinn, IW Byrd, JC
Citation: Jk. Waselenko et al., Gemcitabine demonstrates in vitro activity against human B-cell chronic lymphocytic leukemia, LEUK RES, 25(6), 2001, pp. 435-440
Novel therapies for chronic lymphocytic leukemia in the 21st century
Authors: Byrd, JC Waselenko, JK Keating, M Rai, K Grever, MR
Citation: Jc. Byrd et al., Novel therapies for chronic lymphocytic leukemia in the 21st century, SEMIN ONCOL, 27(5), 2000, pp. 587-597
Theophylline, pentostatin (Nipent), and chlorambucil: A dose-escalation study targeting intrinsic biologic resistance mechanisms in patients with relapsed lymphoproliferative disorders
Authors: Byrd, JC Grever, MR Waselenko, JK Willis, CR Park, K Goodrich, A Lucas, MA Shinn, C Flinn, IW
Citation: Jc. Byrd et al., Theophylline, pentostatin (Nipent), and chlorambucil: A dose-escalation study targeting intrinsic biologic resistance mechanisms in patients with relapsed lymphoproliferative disorders, SEMIN ONCOL, 27(2), 2000, pp. 37-40
Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia
Authors: Waselenko, JK Grever, MR Beer, M Lucas, MA Byrd, JC
Citation: Jk. Waselenko et al., Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia, SEMIN ONCOL, 27(2), 2000, pp. 44-51
Rituximab therapy in hematologic malignancy patients with circulating blood tumor cells: Association with increased infusion-related side effects andrapid blood tumor clearance
Authors: Byrd, JC Waselenko, JK Maneatis, TJ Murphy, T Ward, FT Monahan, BP Sipe, MA Donegan, S White, CA
Citation: Jc. Byrd et al., Rituximab therapy in hematologic malignancy patients with circulating blood tumor cells: Association with increased infusion-related side effects andrapid blood tumor clearance, J CL ONCOL, 17(3), 1999, pp. 791-795
Stem-cell transplantation in chronic lymphocytic leukemia: The time for designing randomized studies has arrived
Authors: Waselenko, JK Flynn, JM Byrd, JC
Citation: Jk. Waselenko et al., Stem-cell transplantation in chronic lymphocytic leukemia: The time for designing randomized studies has arrived, SEMIN ONCOL, 26(1), 1999, pp. 48-61
Depsipeptide (FR901228): A novel therapeutic agent with selective, in vitro activity against human B-cell chronic lymphocytic leukemia cells
Authors: Byrd, JC Shinn, C Ravi, R Willis, CR Waselenko, JK Flinn, IW Dawson, NA Grever, MR
Citation: Jc. Byrd et al., Depsipeptide (FR901228): A novel therapeutic agent with selective, in vitro activity against human B-cell chronic lymphocytic leukemia cells, BLOOD, 94(4), 1999, pp. 1401-1408
Preservation of nucleic acids for polymerase chain reaction after prolonged storage at room temperature
Authors: Tuttle, RM Waselenko, JK Yosseffi, P Weigand, N Martin, RK
Citation: Rm. Tuttle et al., Preservation of nucleic acids for polymerase chain reaction after prolonged storage at room temperature, DIAGN MOL P, 7(6), 1998, pp. 302-309
Women with thrombophilia: Assessing the risks for thrombosis with oral contraceptives or hormone replacement therapy
Authors: Waselenko, JK Nace, MC Alving, B
Citation: Jk. Waselenko et al., Women with thrombophilia: Assessing the risks for thrombosis with oral contraceptives or hormone replacement therapy, SEM THROMB, 24, 1998, pp. 33-39
Risultati: 1-11 |